FI971492L - Indolijohdannaiset 5-HT1-tyyppisinä agonisteina - Google Patents

Indolijohdannaiset 5-HT1-tyyppisinä agonisteina Download PDF

Info

Publication number: FI971492L
Authority: FI; Finland
Prior art keywords: indole derivatives; type agonists; agonists; type; indole
Prior art date: 1994-10-11

Application number

FI971492A

Other languages

English (en)

Swedish (sv)

Other versions

FI113863B (fi

FI971492A0 (fi

Inventor

Alan Daniel Brown

Original Assignee

Pfizer Res & Dev

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-11

Filing date

1997-04-10

Publication date

1997-04-10

1997-04-10 Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev

1997-04-10 Publication of FI971492A0 publication Critical patent/FI971492A0/fi

1997-04-10 Publication of FI971492L publication Critical patent/FI971492L/fi

2004-06-30 Application granted granted Critical

2004-06-30 Publication of FI113863B publication Critical patent/FI113863B/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Anesthesiology (AREA)
Child & Adolescent Psychology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Toxicology (AREA)
Hospice & Palliative Care (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)

FI971492A 1994-10-11 1997-04-10 Indolijohdannaiset 5-HT1-tyyppisinä agonisteina FI113863B (fi)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB9420503		1994-10-11
GB9420503A GB9420503D0 (en)	1994-10-11	1994-10-11	Therapeutic agents
EP9503884		1995-09-29
PCT/EP1995/003884 WO1996011195A1 (en)	1994-10-11	1995-09-29	Indole derivatives as 5ht1-like agonists

Publications (3)

Publication Number	Publication Date
FI971492A0 FI971492A0 (fi)	1997-04-10
FI971492L true FI971492L (fi)	1997-04-10
FI113863B FI113863B (fi)	2004-06-30

Family

ID=10762688

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI971492A FI113863B (fi)	1994-10-11	1997-04-10	Indolijohdannaiset 5-HT1-tyyppisinä agonisteina

Country Status (11)

Country	Link
US (1)	US5770611A (fi)
EP (1)	EP0785933B1 (fi)
JP (1)	JP2902484B2 (fi)
AT (1)	ATE163934T1 (fi)
DE (1)	DE69501791T2 (fi)
DK (1)	DK0785933T3 (fi)
ES (1)	ES2113213T3 (fi)
FI (1)	FI113863B (fi)
GB (1)	GB9420503D0 (fi)
GR (1)	GR3026532T3 (fi)
WO (1)	WO1996011195A1 (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9420529D0 (en)	1994-10-12	1994-11-30	Pfizer Ltd	Indoles
US7189753B1 (en)	1997-11-06	2007-03-13	Cady Roger K	Preemptive prophylaxis of migraine
CA2309350C (en)	1997-11-12	2007-04-03	Mitsubishi Chemical Corporation	Purine derivatives and medicaments comprising the same as active ingredient
US7459473B2 (en)	1998-06-03	2008-12-02	Glia Med, Inc.	N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxylic acid isosteres
KR100747106B1 (ko)	1999-05-11	2007-08-08	미쯔비시 가가꾸 가부시끼가이샤	퓨린 유도체 이수화물, 이를 유효성분으로 함유하는 의약및 이의 제조 중간체
WO2011158149A1 (en)	2010-06-18	2011-12-22	Pfizer Inc.	2-(3,5-disubstitutedphenyl)pyrimidin-4(3h)-one derivatives
WO2025104491A1 (en) *	2023-11-14	2025-05-22	Mindset Pharma Inc.	Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5545644A (en) *	1990-10-15	1996-08-13	Pfizer Inc.	Indole derivatives
US5607951A (en) *	1990-10-15	1997-03-04	Pfizer Inc	Indole derivatives
US5559246A (en) *	1990-10-15	1996-09-24	Pfizer Inc.	Indole derivatives
US5578612A (en) *	1990-10-15	1996-11-26	Pfizer Inc.	Indole derivatives
US5559129A (en) *	1990-10-15	1996-09-24	Pfizer Inc	Indole derivatives
ATE190608T1 (de) *	1991-11-25	2000-04-15	Pfizer	5-(hetero- oder carbocyclylamino)-indol derivate, deren herstellung und deren verwendung als 5-ht1 agonisten
US5409941A (en) *	1992-02-03	1995-04-25	Pfizer Inc.	5-heteroyl indole derivatives
TW288010B (fi) *	1992-03-05	1996-10-11	Pfizer
CZ282653B6 (cs) *	1992-04-10	1997-08-13	Pfizer Inc.	Acylaminoindolové deriváty představující 5-HT1 agonisty, způsob jejich přípravy, farmaceutické prostředky obsahující tyto látky, jejich použití a meziprodukty postupu přípravy
GB9207930D0 (en) *	1992-04-10	1992-05-27	Pfizer Ltd	Indoles
GB9208161D0 (en) *	1992-04-14	1992-05-27	Pfizer Ltd	Indoles
EP0695301B1 (en) *	1993-04-22	1996-10-30	Pfizer Limited	Indole derivatives as 5-ht1-like agonists for use in migraine
GB9424471D0 (en) *	1994-12-03	1995-01-18	Pfizer Ltd	Treatment of emesis

1994
- 1994-10-11 GB GB9420503A patent/GB9420503D0/en active Pending
1995
- 1995-09-29 WO PCT/EP1995/003884 patent/WO1996011195A1/en not_active Ceased
- 1995-09-29 JP JP8512312A patent/JP2902484B2/ja not_active Expired - Fee Related
- 1995-09-29 EP EP95934124A patent/EP0785933B1/en not_active Expired - Lifetime
- 1995-09-29 ES ES95934124T patent/ES2113213T3/es not_active Expired - Lifetime
- 1995-09-29 US US08/809,600 patent/US5770611A/en not_active Expired - Fee Related
- 1995-09-29 AT AT95934124T patent/ATE163934T1/de not_active IP Right Cessation
- 1995-09-29 DE DE69501791T patent/DE69501791T2/de not_active Expired - Fee Related
- 1995-09-29 DK DK95934124.9T patent/DK0785933T3/da active
1997
- 1997-04-10 FI FI971492A patent/FI113863B/fi active
1998
- 1998-04-03 GR GR980400716T patent/GR3026532T3/el unknown

Also Published As

Publication number	Publication date
JP2902484B2 (ja)	1999-06-07
GB9420503D0 (en)	1994-11-23
WO1996011195A1 (en)	1996-04-18
MX9702643A (es)	1997-07-31
US5770611A (en)	1998-06-23
FI113863B (fi)	2004-06-30
GR3026532T3 (en)	1998-07-31
DK0785933T3 (da)	1998-05-11
ES2113213T3 (es)	1998-04-16
DE69501791D1 (de)	1998-04-16
FI971492A0 (fi)	1997-04-10
EP0785933A1 (en)	1997-07-30
EP0785933B1 (en)	1998-03-11
DE69501791T2 (de)	1998-07-02
JPH09512034A (ja)	1997-12-02
ATE163934T1 (de)	1998-03-15

Publication	Publication Date	Title
FI944805A0 (fi)	1994-10-12	Indolijohdannaisia 5-HT1-kaltaisina agonisteina
FI944969A7 (fi)	1995-04-23	Indolijohdannaisia
DE69735712D1 (de)	2006-05-24	Aryl-pyrimidin-derivate
DK0891332T3 (da)	2004-07-05	6-phenylpyridyl-2-aminderivater
KR950700906A (ko)	1995-02-20	5-ht1 작동약으로서의 인돌 유도체(indole derivatives as 5-ht1 agonists)
IS4800A (is)	1998-07-21	Nýjar 19-nor-pregnene afleiður
FI972275A7 (fi)	1997-05-29	Indolijohdannainen
NO981946D0 (no)	1998-04-29	Imidazoquinazolin-derivater
NO961475L (no)	1996-04-12	Indol-derivater
FI962969A7 (fi)	1996-07-25	Indolijohdannaisia 5-HT1:n agonisteina
DE69732576D1 (de)	2005-03-31	Tetrahydrobenzindolon-derivate
FI950568A7 (fi)	1995-08-11	5-heteroaryyli-indolijohdannaiset
FI944727L (fi)	1994-10-07	Indolijohdannaisia 5-HT1:n kaltaisina agonisteina
IS5026A (is)	1999-04-15	2-metoxýfenýlpíperasín afleiður
FI971492L (fi)	1997-04-10	Indolijohdannaiset 5-HT1-tyyppisinä agonisteina
DK0725061T3 (da)	2000-10-02	Substituerede indolderivater
FI960730L (fi)	1996-02-16	Indolijohdannaiset 5alfa-reduktaasi-1-inhibiittoreina
DE69710921D1 (de)	2002-04-11	Heterocyclische substituierte pyrrolidinamid-derivate
FI965181L (fi)	1998-06-21	Polyalkoholi-peptidijohdannaiset
DE59605373D1 (de)	2000-07-13	Substituierte Indol-Derivate
ATA69896A (de)	1997-05-15	3-methylimino-3-cephemderivate 3-methylimino-3-cephemderivate
ATA73396A (de)	1997-05-15	3-methylimino-3-cephemderivate 3-methylimino-3-cephemderivate

Legal Events

Date	Code	Title	Description
2006-10-02	PC	Transfer of assignment of patent	Owner name: PFEIZER IRELAND PHARMACEUTICALS Free format text: PFEIZER IRELAND PHARMACEUTICALS

Date

Code

Title

Description

2006-10-02

Transfer of assignment of patent

Owner name: PFEIZER IRELAND PHARMACEUTICALS

Free format text: PFEIZER IRELAND PHARMACEUTICALS